Schedule 13G ownership disclosure

Elevai Labs Inc.

Common Stock, $0.0001 par value · CUSIP: 28622K104

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Anson Funds Management LP

    Shares: 1,060,505 · Class: 4.9%

  • Anson Management GP LLC

    Shares: 1,060,505 · Class: 4.9%

  • Tony Moore

    Shares: 1,060,505 · Class: 4.9%

  • Anson Advisors Inc.

    Shares: 1,060,505 · Class: 4.9%

  • Amin Nathoo

    Shares: 1,060,505 · Class: 4.9%

  • Moez Kassam

    Shares: 1,060,505 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-021626
Form type
SCHEDULE 13G/A
Filer
Anson Funds Management LP
CIK
CIK 1491072
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub